Moderna Spikevax Vaccine

Moderna is an American biotechnology and pharmaceutical company pioneering messenger RNA (mRNA) therapeutics and vaccines. Established in Cambridge, Massachusetts, the company achieved global prominence with the development of Spikevax, its COVID-19 mRNA vaccine, which has been widely authorized and administered across the United Kingdom.

Global manufacturing of Moderna's vaccines relies on an international network of contract manufacturing and internal facilities. While active substance synthesis and formulation take place across facilities in the United States, Switzerland (Lonza), and Spain (ROVI), Moderna has also established dedicated mRNA manufacturing and research infrastructure in the United Kingdom, specifically through the Moderna Innovation and Technology Centre (MITC) in Oxfordshire.

The brand remains an independent publicly traded enterprise headquartered in the United States. In the UK, its distribution, commercial activities, and partnerships with the NHS and UK Health Security Agency (UKHSA) are managed through its local operating subsidiary, Moderna Biotech UK Limited. Note that other unrelated commercial entities share the name Moderna in different industries (such as homeware or furniture brands), but in the UK healthcare and consumer sector, Moderna uniquely identifies the biopharmaceutical company.